-
Cost-Consequence of Incorporating Single-Operator Direct Visualization Cholangioscopy in the Diagnosis of Indeterminate Biliary Strictures in Saudi Arabia
Sep 9, 2025, 16:22 PM -
How the EU JCA Could Interface With Regional Pricing Alliances (BeNeLuxA, Nordic Forum, Valletta Group) and EU-Level Procurement Under the Critical Medicines Act
Sep 9, 2025, 16:22 PM -
Updated Projections of HPV Vaccine Coverage Growth in Europe: Are Countries on Track to Meet WHO's 2030 Target?
Sep 9, 2025, 16:22 PM -
Facilitating Investment in Obesity Care and Prevention: A Societal Cost Benefit Analysis for the Netherlands
Sep 9, 2025, 16:22 PM -
Burden of Illness Among Patients With Transfusion Dependent Beta-Thalassemia in Spain: A Registry-Based Study
Sep 9, 2025, 16:22 PM -
Transportability of Overall Survival Estimates From the United States to Germany in EGFRm Advanced NSCLC Patients Post-Tyrosine Kinase Inhibitor (TKI) Treatment
Sep 9, 2025, 16:22 PM -
Biomarker Levels in Patients With Crohn’s Disease Post-Advanced Therapy Induction: A Real-World Survey in Europe
Sep 9, 2025, 16:22 PM -
Hospital Community Integration: The Case of the Territorial Oncology Center at ASL 04 Teramo
Sep 9, 2025, 16:22 PM -
Why Current HTA Frameworks Fall Short for Anti-Cancer Combination Therapies: Toward Equitable Value Attribution and Policy Reform
Sep 9, 2025, 16:22 PM -
Adoption of AI Clinical Decision Support Systems in Primary Care: An Evaluation of Physician Acceptance
Sep 9, 2025, 16:22 PM -
Out-of-Work Transitions in the European Population With Noncommunicable Diseases
Sep 9, 2025, 16:22 PM -
Economic Evaluation of the RESET Study Weight Loss Phase: Impact on Event Risk Reduction and Cost-Effectiveness in Type 2 Diabetes Management
Sep 9, 2025, 16:22 PM -
Triangulation Method to Detect Meaningful Deterioration in Patient's Autonomy Using the New Multiple Sclerosis Autonomy Scale (MSAS) Questionnaire
Sep 9, 2025, 16:22 PM -
Public Health and Economic Impact of RSVpreF Vaccination Among Older Adults in Latin America and the Caribbean
Sep 9, 2025, 16:22 PM -
Comparison of Persistence Rates: Tildrakizumab vs. Adalimumab/Ustekinumab Based on a German Longitudinal Prescription Database (LRx) of Social Health Insurance Patients in Outpatient Care
Sep 9, 2025, 16:22 PM -
Evaluating the Impact of Censoring on Progression-Free Survival Comparisons of BCMA-Targeting Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma
Sep 9, 2025, 16:22 PM -
NCFBE Hospitalizations Costs Across Different Healthcare Systems: Insights From England and France in 2022 Using PMSI and HES Databases
Sep 9, 2025, 16:22 PM -
Real-World Drivers of Adherence in Obesity Highlight the Need for Patient-Centered Interventions
Sep 9, 2025, 16:22 PM -
Healthcare Resource Use Among Patients With Chronic Rhinosinusitis With Nasal Polyps in the United Kingdom: Results of an Expert Elicitation Survey
Sep 9, 2025, 16:22 PM -
Impact of Individualized Neoantigen Therapies on Health, Productivity, and Health System Capacity Outcomes in Resected Melanoma in Belgium
Sep 9, 2025, 16:22 PM
